The PE Ratio as of December 2025 (TTM) for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) is 56.14

According to HPGC Renmintongtai Pharmaceutical Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 56.14. This represents a change of -7.64% compared to the average of 60.78 of the last 4 quarters.

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) Historical PE Ratio (quarterly & annually)

How has 600829.SS PE Ratio performed in the past?

The mean historical PE Ratio of HPGC Renmintongtai Pharmaceutical Corporation over the last ten years is 25.76. The current 56.14 PE Ratio has changed 21.69% with respect to the historical average. Over the past ten years (40 quarters), 600829.SS's PE Ratio was at its highest in in the December 2015 quarter at 1.61K. The PE Ratio was at its lowest in in the June 2021 quarter at 8.92.

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of HPGC Renmintongtai Pharmaceutical Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) Average PE Ratio

How has 600829.SS PE Ratio performed in the past?

The current PE Ratio of HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) PE Ratio vs. Peers

How is 600829.SS’s PE Ratio compared to its peers?

HPGC Renmintongtai Pharmaceutical Corporation’s PE Ratio is greater than Ningbo Menovo Pharmaceutical Co., Ltd. (42.66), greater than Fuan Pharmaceutical (Group) Co., Ltd. (38.70), greater than Hunan Fangsheng Pharmaceutical Co., Ltd. (16.99), greater than Jinhe Biotechnology Co. Ltd. (36.43), greater than Tianjin Lisheng Pharmaceutical Co.,Ltd. (13.74), greater than Tibet Weixinkang Medicine Co., Ltd. (21.38), greater than Yabao Pharmaceutical Group Co., Ltd (20.83), less than Beijing Beilu Pharmaceutical Co., Ltd (128.21), less than Teyi Pharmaceutical Group Co.,Ltd (69.53), less than LanZhou Foci Pharmaceutical Co.,Ltd. (82.29),

Build a custom stock screener for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HPGC Renmintongtai Pharmaceutical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HPGC Renmintongtai Pharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.